Press Release – New York, NY – February 5, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a clinical-stage …
Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $5.5 Million Public Offering
Press Release – New York, NY – December 12, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a clinical-stage …
Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in the $12.2 Million Registered Direct Offering of 374Water Inc.
New York, NY - November 18, 2024 - Sichenzia Ross Ference Carmel LLP announced that it represented D. Boral Capital LLC as the exclusive placement agent for the $12.2 million registered direct …
Sichenzia Ross Ference Carmel LLP Represents Joseph Gunnar & Co., LLC in the $1.6 Million Private Placement Offering of Eastside Distilling, Inc.
New York, NY - November 18, 2024 - Sichenzia Ross Ference Carmel LLP announced that it represented Joseph Gunnar & Co., LLC as the exclusive placement agent for the $1.6 million private placement …
Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $4.2 Million Initial Public Offering of Polyrizon Ltd.
New York, NY – October 30, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Aegis Capital Corp. as sole book running manager in the initial public offering of Polyrizon Ltd. …
Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $5.0 Million Offering
Press Release – New York, NY – October 1, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a clinical-stage …
